Silicon is generally, without modification in the chip such as deep trench isolation, not that sensitive to NIR. This means that in some cases alternative materials such as InGaAs or Ge are deployed. Organic semiconductors have now shown excellent results with 65% EQE at NIR. Silicon- even with modification- struggles to reach this level of performance. Silicon is generally not very sensitive to NIR. As such many approaches are being developed to make it sensitive to NIR. One such approach is to develop hybrid sensors consisting of organic or quantum dots atop a specially designed Si CMOS ROIC (read-out-circuit). In such approaches the EQE is generally not high- it hovers around the 20% mark. In the case of this development, demonstrated by Raynergy Tek, an advanced materials firm in Taiwan focusing mainly on organic photodetectors and organic photovoltaics, the EQE has reached 65% at 940nm. The device structure is shown below. Of course, to the best my knowledge, these appear to be hero cells made on a glass substrate. They are still a far cry from a true solution processed organic on CMOS hybrid imager with a resolution of VGA and above. To get there, many developments will still be needed including the development of a special ROIC, the development of a process to cast (or otherwise deposit) the entire OPD stack onto of the CMOS ROIC, patternig it without loss of EQE, ensuring stability, etc Nonetheless, this is a fantastic demonstrator, showing the potential. In subseque...

after Continuous Glucose Monitoring (CGM) devices Speaker: Robert Batchelor | Company: Nutromics | Date: 13-14 October 2021 | Full Presentation There is a clinical need for continuous monitoring of vital molecular biomarkers and drug concentrations. However, with the exception of venous oxygen and glucose, these concentrations are currently determined via lab tests. Lab testing costs valuable time, which is relevant for transient biomarkers and critically sick patients. Additionally, lab testing is intermittent at best, and requires infrastructure, reagents, and skilled operators, which aren’t always available in remote locations. Electrochemical aptamer-based (EAB) sensors, invented and developed by Prof. Kevin Plaxco at the University of California, Santa Barbara, can be adapted for multiple molecular targets, are reagent-free, and work in-vivo, thus enabling on-body wearable devices. Nutromics is integrating the EAB technology into a wearable ‘lab on the skin’ to meet the pressing clinical need of monitoring molecular biomarkers and drugs. In this presentation I will discuss the EAB sensor technology, how it compares with continuous glucose monitors, the advantages and limitations of the technology, and finally, the potential of Continuous Molecular Monitoring (CMM) wearable devices using EAB sensors. Join TechBlick on an annual pass to join all live online conference or online version of onsite conference access library of on-demand talks (600 talks + PDFs) portfolio o...

Speaker: Sophia Krinner | Company: Karl Mayer Stoll R&D | Date: 13-14 October 2021 | Full Presentation This talk will illustrate possibilities for the field of e-textiles by warp knitted products. Already today highly functional products in the fields of active & sportswear, lingerie, outerwear, automotive and agricultural fabrics are based on warp knitted materials. During this highly productive production process fabrics can be functionalized, therefore warp knitted fabrics will enrich the chances of e-textiles and change the market. In this presentation you will see different functional systems done by this technology including a coil for inductive charging and a sensor shirt to detect vital parameters. Join TechBlick on an annual pass to join all live online conference or online version of onsite conference access library of on-demand talks (600 talks + PDFs) portfolio of expert led masterclass year-round platform https://www.techblick.com/ And do NOT miss our flagship event in Berlin on 17-18 OCT 2023 focused on Reshaping the Future of Electronics. This event attracts 550-600 participants from all the world and offers a superb ambience and dynamic exhibition floor. To learn more visit https://www.techblick.com/electronicsreshaped To see feedback about previous event see https://www.techblick.com/events-agenda...

Speaker: Anders Strömberg | Company: Sony | Date: 13-14 October 2021 | Full Presentation In this talk, Anders Strömberg, Director, Head of Wearable Platform Division, Sony Network Communications Europe, will discuss the issue of trust in IoT devices for remote monitoring, the challenges and some possible solutions. Care providers need to monitor the wellbeing of their patients. That means staying connected with them wherever they are, whatever they’re doing. Most of today’s remote monitoring applications require pairing with cell phones or smartwatches, using standard LTE connectivity. Healthcare providers are continuously seeking to increase the quantity and quality of information available, and to offer end-users more practical, timely insights. How can they do this while also providing solutions that are as easy for all kinds of end-users to handle? The answer lies in the convergence of new IoT, telecommunications and AI technologies which enable access to rich data and allow service providers to develop new solutions; solutions that, for example, improve adherence to prescriptions, enable early detection of conditions like diabetes and boost the users’ general health and wellbeing. Both service providers and end users show a high level of acceptance and willingness to adopt these new technologies in the pursuit of better health and health services. However, there are some serious trust issues when it comes to IoT. Although the risks are not new, concerns have risen to a...

Speaker: Dennis Hahn | Company: Airbus Operations GmBH | Date: 11-12 May 2021 | Full Presentation Join TechBlick on an annual pass to join all live online conference or online version of onsite conference access library of on-demand talks (600 talks + PDFs) portfolio of expert led masterclass year-round platform https://www.techblick.com/ And do NOT miss our flagship event in Berlin on 17-18 OCT 2023 focused on Reshaping the Future of Electronics. This event attracts 550-600 participants from all the world and offers a superb ambience and dynamic exhibition floor. To learn more visit https://www.techblick.com/electronicsreshaped To see feedback about previous event see https://www.techblick.com/events-agenda...

Speaker: Philipp Rouast | Company: Rouast Labs | Date: 13-14 October 2021 | Full Presentation Simple RGB video of the human face gives away physiological information through tiny changes in skin color and motion — imperceptible to the human eye, but measurable by the computer to produce estimates of vital signs such as heart rate and respiration rate. The technology that accomplishes this is know as remote photoplethysmography (rPPG), highlighting its major advantage of not requiring physical contact between subject and sensor. First proposed in 2008, rPPG has yet to be widely commercialized. This is in part due to the difficulty in obtaining reliable measurements in challenging real-world conditions, especially regarding illumination conditions and subject movement. This talk will (i) introduce the basis for the signals obtained with camera sensors, (ii) walk through the technological improvements made by researchers since 2008, and (iii) summarize current issues and give an outlook on future applications. Join TechBlick on an annual pass to join all live online conference or online version of onsite conference access library of on-demand talks (600 talks + PDFs) portfolio of expert led masterclass year-round platform https://www.techblick.com/ And do NOT miss our flagship event in Berlin on 17-18 OCT 2023 focused on Reshaping the Future of Electronics. This event attracts 550-600 participants from all the world and offers a superb ambience and dynamic exhibition floor. T...

Speaker: Ahmad Qasem | Company: Atcor | Date: 13-14 October 2021 | Full Presentation Current wearable sensor technologies provide limited and less reliable health parameters based mainly on heart rate measurement. Any reliable cardiovascular health assessment requires blood pressure measurements. Many attempts had been made to provide blood pressure measurements using commercially available wearable sensors like in smart watches. However, all attempts failed in measuring blood pressure as required by medical standards. On the other hand, FDA cleared Cardiex\AtCor medical technology became the ‘gold standard’ in measuring non-invasively heart and arterial pressure parameters reflecting cardiac and arterial health. The challenge is to adapt such medical technology into the wearable sensor devices. This involves examining different and new sensors. It also involve new methods of sensor signals based on cardiovascular physiology to extract clinically significant central arterial pressure parameters. This presentation will review current health wearable technologies, challenges in providing reliable cardiovascular health assessment, and Cardiex current development of medical wearable devices to provide clinical heart and arterial health assessments. Join TechBlick on an annual pass to join all live online conference or online version of onsite conference access library of on-demand talks (600 talks + PDFs) portfolio of expert led masterclass year-round platform https://...

with Continuous Mobility Assessment Speaker: Alexis Mathieu | Company: FeetMe | Date: 13-14 October 2021 | Full Presentation Bringing a drug to market is long and difficult. Studies estimate that the clinical trial process lasts 9 years and costs $1.3B on average. Clinical trials are conducted in multiple phases, with cost and complexity increasing from Phase I to Phase III. Despite the time and capital invested in trials, only 1 in 10 drugs that enter Phase I of a clinical trial will be approved by the FDA. There is Large medical need to evaluate to treat the physical deterioration of physical status. A growing number of patients with mobility impairments lacks accurate tools to diagnose, monitor expensive evolutive diseases and intervene efficiently. Gait is the simplest and most actionable biomarker to monitor multiple diseases but vastly underutilized as a biomarker or outcome measure because gait analysis is often not high quality when assessed in the clinic.Clinical gait tests, today, are used to identify mobility disorders, measure the efficacy of a therapeutic treatment. This is done in a controlled setting at sites. However, the technologies or design used present strong limitations. Episodic assessments, sometimes observational, don't generate sufficient sensitive data to demonstrate subtle changes. The FeetMe solution allows the collection of validated gait data at site with the Insoles, and in the same accurate way in the patients daily life allowing continuou...